United States - English - NLM (National Library of Medicine)

american health packaging - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dasco proprietary limited - nitric acid; sulfamic acid - aqueous concentrate - nitric acid acid-general active 206.0 g/l; sulfamic acid mineral-sulfur-acid active 54.0 g/l - dairy cleanser - milking equipment | milking machine - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

United States - English - NLM (National Library of Medicine)

direct_rx - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - these highlights do not include all the information needed to use valproic acid capsules safely and effectively. see full prescribing information for valproic acid capsules. valproic acid capsules for oral use initial u.s. approval: 1978 warning: life threatening adverse reactions see full prescribing information for complete boxed warning. hepatotoxicity, including fatalities, usually during the first 6 months of treatment. children under the age of two years and patients with mitochondrial disorders are at higher risk. monitor patients closely, and perform serum liver testing prior to therapy and at frequent intervals thereafter (5.1) fetal risk, particularly neural tube defects, other major malformations, and decreased iq (5.2, 5.3, 5.4) pancreatitis, including fatal hemorrhagic cases (5.5) indications and usage valproic acid capsules are an anti-epileptic drug indicated for: monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and c

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

lannett company, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

delaval pty ltd - phosphoric acid; sulfuric acid - soluble concentrate - phosphoric acid mineral-phosphorus-acid active 213.0 g/l; sulfuric acid mineral-sulfur-acid active 116.0 g/l - dairy cleanser - milk tank | milk vat | milking equipment | bulk milk vat | milking machine - detergent sanitiser | milkstone removal | milk fat | milk protein | mineral deposits

United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917), colchicine (unii: sml2y3j35t) (colchicine - unii:sml2y3j35t) - probenecid 500 mg - for the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. hypersensitivity to this product or to probenecid or colchicine. probenecid and colchicine tablets are contraindicated in children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid and colchicine should not be started until an acute gouty attack has subsided. pregnancy: probenecid crosses the placental barrier and appears in cord blood. colchicine can arrest cell division in animals and plants. in certain species of animal under certain conditions, colchicine has produced teratogenic effects. the possibility of such effects in humans also has been reported. because of the colchicine component, probenecid and colchicine is contraindicated in pregnant patients. the use of any drug in women of child bearing potential requires that the anticipated benefit be weighed against the possible hazards.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917), colchicine (unii: sml2y3j35t) (colchicine - unii:sml2y3j35t) - probenecid 500 mg - for the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. hypersensitivity to this product or to probenecid or colchicine. probenecid and colchicine tablets are contraindicated in children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid and colchicine should not be started until an acute gouty attack has subsided. probenecid crosses the placental barrier and appears in cord blood. colchicine can arrest cell division in animals and plants. in certain species of animals under certain conditions, colchicine has produced teratogenic effects. the possibility of such effects in humans also has been reported. because of the colchicine component, probenecid and colchicine is contraindicated in pregnant patients. the use of any drug in women of childbearing potential requires that the anticipated benefit be weighed against the possible hazards.

United States - English - NLM (National Library of Medicine)

hhs/program support center/supply service center - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.